Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 9, 2013 - Issue 9
Submit an article Journal homepage
214
Views
3
CrossRef citations to date
0
Altmetric
Reviews

Prevention of anaphylaxis in healthcare settings

Allison WorthAllergy & Respiratory Research Group, Centre for Population Health Sciences, The University of Edinburgh, Medical School, Edinburgh EH8 9AG, UK
&
Aziz SheikhAllergy & Respiratory Research Group, Centre for Population Health Sciences, The University of Edinburgh, Medical School, Edinburgh EH8 9AG, UKCorrespondence[email protected]
Pages 855-869 | Published online: 10 Jan 2014

References

  • Simons FER, Ardusso LRF, Bilo MB et al. World Allergy Organization guidelines for the assessment and management of anaphylaxis. J. Allergy Clin. Immunol. 127, 587–593 (2011).
  • Sampson HA, Muñoz-Furlong A, Campbell RL et al. Second symposium on the definition and management of anaphylaxis: summary report – Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J. Allergy Clin. Immunol. 117, 391–397 (2006).
  • Soar J, Pumphrey R, Cant A et al. Emergency treatment of anaphylactic reactions – guidelines for healthcare providers. Resuscitation 77, 157–169 (2008).
  • Lieberman P, Niklas RA, Oppenheimer J, Kemp SF, Lang DM. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J. Allergy Clin. Immunol. 126, 477–480 (2010).
  • Decker WW, Campbell RL, Manivannan V et al. The etiology and incidence of anaphylaxis in Rochester, Minnesota: a report from the Rochester Epidemiology Project. J. Allergy Clin. Immunol. 122, 1161.1165 (2008).
  • Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clin. Exp. Allergy 31, 1571–1576 (2001).
  • Pumphrey RSH. Lessons for management of anaphylaxis from a study of fatal reactions. Clin. Exp. Allergy 30, 1144–1150 (2000).
  • Pumphrey RSH. Fatal anaphylaxis in the UK 1992–2001. In: Anaphylaxis. Novartis Foundation Symposium 257. John Wiley & Sons, London, UK, 116–132 (2004).
  • Panesar SS, Nwaru BI, Hickstein L et al.; European Academy of Allergy and Clinical Immunology Food Allergy and Anaphylaxis Guidelines group. The epidemiology of anaphylaxis in Europe: protocol for a systematic review. Clin. Transl. Allergy 3(1), 9 (2013).
  • Shen Y, Li L, Grant J et al. Anaphylactic deaths in Maryland (United States) and Shanghai (China): a review of forensic autopsy cases from 2004 to 2006. Forensic Sci. Int. 186, 1–5 (2009).
  • Liew WK, Williamson E, Tang MLK. Anaphylaxis fatalities and admissions in Australia. J. Allergy Clin. Immunol. 123, 434–442 (2009).
  • Ewan PW, Dugué P, Mirakian R, Dixon TA, Harper JN, Nasser SM. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin. Exp. Allergy 40, 15–31 (2010).
  • Harper NJN, Dixon T, Dugué P et al. Suspected anaphylactic reactions associated with anaesthesia. Anaesthesia 64, 199–211 (2009).
  • Rolland, JM, O'Hehir RE. Latex allergy: a model for therapy. Clin. Exp. Allergy 38, 898–912 (2008).
  • Liccardi G, D’Amato G, Canonica GW, Salzillo A, Piccolo A, Passalacqua G. Systemic reactions from skin testing: literature review. J. Investig. Allergol. Clin. Immunol. 16, 75–78 (2006).
  • Heinzerling L, Mari A, Bergmann KC et al. The skin prick test-European standards. Clin. Transl. Allergy 3, 3 (2013).
  • White JML. Patch testing: what allergists should know. Clin. Exp. Allergy 42, 180–185 (2012).
  • Soares-Weiser K, Panesar SS, Rader T et al. EAACI Food Allergy and Anaphylaxis Group. The diagnosis of food allergy: protocol for a systematic review. Clin Transl Allergy. 3(1), 18 (2013).
  • Mirakian R, Ewan PW, Durham SR et al. BSACI guidelines for the management of drug allergy. Clin. Exp. Allergy 39, 43–61 (2009).
  • Nowak-Wegrzyn A, Assa'ad AH, Bahna SL, Bock SA, Sicherer SH, Teuber SS. Work Group report: oral food challenge testing. J. Allergy Clin. Immunol. 123, S365 (2009).
  • Boyce J, Assa’ad A, Burks WS et al. Guidelines for the diagnosis and management of food allergy in the United States: Report of the NIAID-Sponsored expert panel. J. Allergy Clin. Immunol. 126, S1–S58 (2010).
  • Nurmatov U, Devereux G, Worth A, Healy L, Sheikh A. Effectiveness and safety of orally-administered immunotherapy for food allergy: systematic review and meta-analysis. Br. J. Nutr. (2013) ( Epub ahead of print).
  • Brockow K. Immediate and delayed cutaneous reactions to radiocontrast media. In: Adverse Cutaneous Drug Eruptions. French LE ( Ed.). Chem Immunol Allergy. 97, Karger, Basel, Switzerland, 180–190 (2012).
  • Brockow K, Romano A, Aberer W et al.; European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity. Skin testing in patients with hypersensitivity reactions to iodinated contrast media-a European multicenter study. Allergy 64, 234–241 (2009).
  • Sheikh A. Glucocorticosteroids in the treatment and prevention of anaphylaxis. Curr. Opin. Allergy Clin. Immunol. 13(3), 263–267 (2013).
  • Thomsen HS. Contrast media safety-An update. Eur. J. Radiol. 80(1), 77–82 (2011).
  • Bae YJ, Hwang YW, Yoon SY et al. The Effectiveness of automatic recommending system for premedication in reducing recurrent radiocontrast media hypersensitivity reactions. PLoS ONE 8(6), e66014 (2013).
  • Kim SH, Jo EJ, Kim MY et al. Clinical value of radiocontrast media skin tests as a prescreening and diagnostic tool in hypersensitivity reactions. Ann. Allergy Asthma Immunol. 110, 258–262 (2013).
  • Delaney A, Carter A, Fisher M. The prevention of anaphylactoid reactions to iodinated radiological contrast media: a systematic review. BMC Med. Imaging. 6, 2 (2006).
  • Tramer MR, von Elm E, Loubeyre P, Hauser C. Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review. BMJ 333, 675 (2006).
  • Cabañes N, Igea JM, de la Hoz B. Latex allergy: position paper. J. Investig. Allergol. Clin. Immunol. 22, 313–330 (2012).
  • Mertes PM, Alla F, Laxenaire MC. Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999–2000. Anesthesiology 99, 536–545 (2003).
  • Liccardi G, Lobefalo G, Di Florio E et al. Strategies for the prevention of asthmatic, anaphylactic and anaphylactoid reactions during the administration of anesthetics and/or contrast media. J. Investig. Allergol. Clin. Immunol. 18, 1–11 (2008).
  • Nakonechna A, Dore P, Dixon T et al. Immediate hypersensitivity to chlorhexidine is increasingly recognised in the United Kingdom. Allergol. Immunopathol. (Madr.) doi:10.1016/j.aller.2012.08.001 (2012) ( Epub ahead of print).
  • Mertes PM, Demoly P, Malinovsky JM. Hypersensitivity reactions in the anesthesia setting/allergic reactions to anesthetics. Curr. Opin. Allergy Clin. Immunol. 12, 361–368 (2012).
  • Silvestri DL, McEnery-Stonelake M. Chlorhexidine: uses and adverse reactions. Dermatitis 24, 112–118 (2013).
  • Beaudouin E, Kanny G, Morisset M et al. Immediate hypersensitivity to chlorhexidine: literature review. Eur. Ann. Allergy Clin. Immunol. 36, 123–126 (2004).
  • Garvey LH, Krøigaard M, Poulsen LK et al. IgE-mediated allergy to chlorhexidine. J. Allergy Clin. Immunol. 120, 409–415 (2007).
  • Jee R, Nel L, Gnanakumaran G, Williams A, Eren E. Four cases of anaphylaxis to chlorhexidine impregnated central venous catheters: a case cluster or the tip of the iceberg? Br. J. Anaesth. 103, 614–615 (2009).
  • Gray PEA, Katelaris CH, Lipson D. Recurrent anaphylaxis caused by topical povidone-iodine (betadine). J. Paediatr. Child Health 49, 504–508 (2013).
  • Yoshida K, Sakurai Y, Kawahara S et al. Anaphylaxis to Polyvinylpyrrolidone in Povidone-Iodine for Impetigo Contagiosum in a boy with atopic dermatitis. Int. Arch. Allergy Immunol. 146, 169–173 (2008).
  • Mertes PM, Malinovsky JM, Jouffroy L et al. Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. J. Investig. Allergol. Clin. Immunol. 21, 442–453 (2011).
  • Barthelmes L, Goyal A, Newcombe RG, McNeill F, Mansel RE. Adverse reactions to patent blue V dye-the NEW START and ALMANAC experience. Eur. J. Surg. Oncol. 36, 399–403 (2010).
  • Caimmi S, Caimmi D, Bousquet PJ, Demoly P. How can we better classify NSAID hypersensitivity reactions? Validation from a large database. Int. Arch. Allergy Immunol. 159, 306–312 (2012).
  • Legere HJIII, Palis RI, Bouza TR, Uluer AZ, Castells MC. A safe protocol for rapid desensitization in patients with cystic fibrosis and antibiotic hypersensitivity. J. Cyst. Fibros. 8, 418–424 (2009).
  • Mertes PM, Alla F, Trechot P et al. Anaphylaxis during anesthesia in France: an 8-year national survey. J. Allergy Clin. Immunol. 128, 366–373 (2011).
  • Kowalski ML, Makowska JS, Blanca M et al. Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)–classification, diagnosis and management: review of the EAACI/ENDA and GA2LEN/HANNA. Allergy 66, 818–829 (2011).
  • Campagna JD, Bond MC, Schabelman E, Hayes BD. The use of cephalosporins in penicillin-allergic patients: a literature review. J. Emerg. Med. 42, 612–620 (2012).
  • Frumin J, Gallagher JC. Allergic cross-sensitivity between penicillin, carbapenem, and monobactam antibiotics: what are the chances? Ann. Pharmacother. 43, 304–315 (2009).
  • Chang C, Mahmood MM, Teuber SS, Gershwin ME. Overview of penicillin allergy. Clin. Rev. Allergy Immunol. 43, 84–97 (2012).
  • Javadi M, Gholami K, Torkamandi H, Hayatshahi A. Penicillin allergy and cross-reactivity with other Beta-lactams. J. Pharm. Care. 1, 29–32 (2013).
  • Hawkey PM, Livermore DM. Carbapenem antibiotics for serious infections. BMJ 344, e3236 (2012).
  • Hepner DL, Castells MC. Anaphylaxis during the perioperative period. Anesth. Analg. 97, 1381–1395 (2003).
  • Warrington R, Silviu-Dan F. Drug allergy. Allergy Asthma Clin. Immunol. 7( Suppl. 1), S10 (2011).
  • Joerger M. Prevention and handling of acute allergic and infusion reactions in oncology. Ann. Oncol. 23 ( Suppl. 10), x313–x319 (2012).
  • Castells MC, Tennant NM, Sloane DE et al. Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases. J. Allergy Clin. Immunol. 122, 574–580 (2008).
  • Carle C, Harper NJ. Anaphylactic reactions associated with anaesthesia. Anaesth. Intens. Care Med. 11(10), 391–393 (2010).
  • Florvaag E, Johansson SG, Öman H et al. Prevalence of IgE antibodies to morphine. Relation to the high and low incidences of NMBA anaphylaxis in Norway and Sweden, respectively. Acta Anaesthesiol. Scand. 49, 437–444 (2005).
  • Kroigaard M, Garvey LH, Gillberg L et al. Scandinavian Clinical Practice Guidelines on the diagnosis, management and follow-up of anaphylaxis during anaesthesia. Acta Anaesthesiol. Scand. 51, 655–670 (2007).
  • Dewachter P, Hepner DL. Anaphylaxis during radiological procedures and in the peri-operative setting. In: Anaphylaxis and Hypersensitivity Reactions. Castells MC ( Ed.). Springer Science Business Media, New York, USA, 183–208 (2011).
  • Fisher MM, Jones K, Rose M. Follow-up after anaesthetic anaphylaxis. Acta Anaesthesiol. Scand. 55, 99–103 (2011).
  • Fisher MM, Doig GS. Prevention of anaphylactic reactions to anaesthetic drugs. Drug Saf. 27, 393–410 (2004).
  • Cronin J, Scorr A, Russell S, McCoy S, Walsh S, O'Sullivan R. A review of a paediatric emergency department vaccination programme for patients at risk of allergy/anaphylaxis. Acta Paediatr. 101(9), 941–945 (2012).
  • Institute of Medicine. Adverse effects of vaccines. Evidence and causality. National Academy of Sciences, Washington DC, USA (2011).
  • Erlewyn-Lajeunesse M, Hunt LP, Heath PT, Finn A. Anaphylaxis as an adverse event following immunisation in the UK and Ireland. Arch. Dis. Child. 97, 487–490 (2012).
  • Wood RA, Berger M, Dreskin SC et al. An algorithm for treatment of patients with hypersensitivity reactions after vaccines. Pediatrics 122, e771 (2008).
  • Clark AT, Skypala I, Leech SC et al. British Society for Allergy and Clinical Immunology guidelines for the management of egg allergy. Clin. Exp. Allergy 40, 1116–1129 (2010).
  • Kelso JM, Greenhawt MJ, Li JT. Adverse reactions to vaccines practice parameter 2012 Update. J. Allergy Clin. Immunol. 130, 25–43 (2012).
  • Tobian AAR, Savage WJ, Tisch DJ, Thoman S, King KE, Ness PM. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 51, 1676–1683 (2011).
  • Tinegate H, Birchall J, Gray A et al. Guideline on the investigation and management of acute transfusion reactions. Br. J. Haematol. 159(2), 143–153 (2012).
  • Martí-Carvajal AJ, Solà I, González LE, Leon de Gonzalez G, Rodriguez-Malagon N. Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions. Cochrane Database Sys. Rev. 6, CD007539. (2010).
  • Hirayama F. Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. Br. J. Haematol. 160, 434–444 (2013).
  • Hansel TT, Kropshofer H, Singer T, Mitchell JA, George AJT. The safety and side effects of monoclonal antibodies. Nat. Rev. Drug Dis. 9, 325–338 (2010).
  • Song X, Long SR, Barber B et al. Systematic review on infusion reactions associated with chemotherapies and monoclonal antibodies for metastatic colorectal cancer. Curr. Clin. Pharmacol. 7, 56–65 (2012).
  • Maggi E, Vultaggio A, Matucci A. Acute infusion reactions induced by monoclonal antibody therapy. Expert Rev. Clin. Immunol. 7, 55–63 (2011).
  • Hong DI, Bankova L, Cahill KN, Kyin T, Castells MC. Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies. Expert Rev. Clin. Immunol. 8, 43–54 (2012).
  • Massanari M, Nelson H, Casale T et al. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma. J. Allergy Clin. Immunol. 125, 383–9 (2010).
  • Lieberman P. The risk and management of anaphylaxis in the setting of immunotherapy. Am. J. Rhinol. Allergy 26, 469–474 (2012).
  • Casale TB, Busse WW, Kline JN et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J. Allergy Clin. Immunol. 117, 134–140 (2006).
  • Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Sys. Rev. 8, CD001186 (2010).
  • Khoriaty E, Umetsu D. Oral immunotherapy for food allergy: towards a new horizon. Allergy Asthma Immunol. Res. 5(1), 3–15 (2013).
  • Bouza TR, Palis RI, Legere HJ III, Castells MC. Rapid desensitizations for antibiotic-induced hypersensitivity reactions and anaphylaxis. In Anaphylaxis and Hypersensitivity Reactions. Castells MC ( Ed.). Springer Science Business Media, New York, USA, 313–331 (2011).
  • Calderon MA, Demoly P, Gerth van Wijk R et al. EAACI: A European Declaration on Immunotherapy. Designing the future of allergen specific immunotherapy. Clin. Transl. Allergy 2, 20 (2012).
  • Lieberman JA, Chehade M. Use of omalizumab in the treatment of food allergy and anaphylaxis. Curr. Allergy Asthma Rep. 13, 78–84 (2013).
  • Kopp MV. Role of immunmodulators in allergen-specific immunotherapy. Allergy 66, 792–797 (2011).
  • Nadeau KC, Schneider LC, Hoyte L, Borras I, Umetsu DT. Rapid oral desensitization in combination with omalizumab therapy in patients with cow’s milk allergy. J. Allergy Clin. Immunol. 127, 1622–1624 (2011).
  • Galera C, Soohun N, Zankar N, Caimmi S, Gallen C, Demoly P. Severe anaphylaxis to bee venom immunotherapy: efficacy of pretreatment and concurrent treatment with omalizumab. J. Investig. Allergol. Clin. Immunol. 19, 225–229 (2009).
  • Kontou-Fili K. High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis. Allergy 63, 376–378 (2008).
  • Simons FER, Sheikh A. Anaphylaxis: the acute episode and beyond. BMJ 346, f602 (2013).
  • Castells M. Rapid desensitization for hypersensitivity reactions to medications. Immunol. Allergy Clin. North Am. 29, 585–606 (2009).
  • Scherer K, Brockow K, Aberer W et al.; for ENDA, the European Network on Drug Allergy and the EAACI Drug Allergy Interest Group. Desensitization in delayed drug hypersensitivity reactions – an EAACI position paper of the Drug Allergy Interest Group. Allergy 68(7), 844–852 (2013).
  • Liu A, Fanning L, Chong H et al. Desensitization regimens for drug allergy: state of the art in the 21st century. Clin. Exp. Allergy 41, 1679–1689 (2011).
  • de Silva HA, Pathmeswaran A, Ranasinha CD et al. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med. 8(5), e1000435 (2011).
  • Habib AG. Effect of pre-medication on early adverse reactions following antivenom use in snakebite: a systematic review and meta-analysis. Drug Saf. 34, 869–880 (2011).
  • Farrar HC, Grayham T, Bolden B, Vyas D, Graham J, James LP. The use and tolerability of Crotalidae Polyvalent Immune FAB (Ovine) in pediatric envenomations. Clin. Pediatr. 51, 945–949 (2012).
  • Weant KA, Bowers RC, Reed J, Braun KA, Dodd DM, Baker SN. Safety and cost-effectiveness of a clinical protocol implemented to standardize the use of Crotalidae Polyvalent Immune Fab Antivenom at an Academic Medical Center. Pharmacotherapy 32, 433–440 (2012).
  • Schaeffer TH, Khatri V, Reifler LM, Lavonas EJ. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae Polyvalent Immune Fab Antivenom: a meta-analysis. Acad. Emerg. Med. 19, 121–131 (2012).
  • Poon EG, Keohane CA, Yoon CS et al. Effect of bar-code technology on the safety of medication administration. N. Engl. J. Med. 362, 1698e707 (2010).
  • Kale A, Keohane CA, Maviglia S, Gandhi TK, Poon EG. Adverse drug events caused by serious medication administration errors. BMJ Qual. Saf. 21, 933–938 (2012).
  • Cresswell KM, Sheikh A. Information technology-based approaches to reducing repeat drug exposure in patients with known drug allergies. J. Allergy Clin. Immunol. 121, 1112–1117 (2008).
  • Cresswell KM, Bates DW, Phansalkar S, Sheikh A. Opportunities and challenges in creating an international centralised knowledge base for clinical decision support systems in ePrescribing. BMJ Qual. Saf. 20, 625–630 (2011).
  • Fernando B, Kalra D, Morrison Z, Byrne E, Sheikh A. Benefits and risks of structuring and/or coding the presenting patient history in the electronic health record: systematic review. BMJ Qual. Saf. 21(4), 337–346 (2012).
  • Babitu UQ, Cyna AM. Patients' understanding of technical terms used during the pre-anaesthetic consultation. Anaesth. Intens. Care 38, 349–353 (2010).
  • Pringle M. Significant event auditing and root cause analysis. In: Health Care Errors and Patient Safety. Hurwitz B, Sheikh A ( Eds) Wiley Blackwell, Chichester, UK, 193–206 (2009).
  • Benn J, Koutantji M, Wallace L et al. Feedback from incident reporting: information and action to improve patient safety. Qual. Saf. Health Care. 18, 11–21 (2009).
  • Simons FE. Anaphylaxis. J. Allergy Clin. Immunol. 121( Suppl.), S402 (2008)
  • Simons FE. Anaphylaxis: recent advances in assessment and treatment. J. Allergy Clin. Immunol. 124, 625–36 (2009).
  • Lee JK, Vadas P. Anaphylaxis: mechanisms and management. Clin. Exp. Allergy. 41, 923–938 (2011).
  • Catley MC, Coote J, Bari M, Tomlinson KL. Monoclonal antibodies for the treatment of asthma. Pharmacol. Ther. 132, 333–351 (2011).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.